444 related articles for article (PubMed ID: 11277368)
1. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene.
Vilaseca MA; Monrós E; Artuch R; Colomé C; Farré C; Valls C; Cardo E; Pineda M
Eur J Paediatr Neurol; 2000; 4(6):269-77. PubMed ID: 11277368
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
Vurucu S; Demirkaya E; Kul M; Unay B; Gul D; Akin R; Gokçay E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):844-8. PubMed ID: 18234410
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
4. Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women.
Kim KN; Kim YJ; Chang N
Eur J Clin Nutr; 2004 Jan; 58(1):10-6. PubMed ID: 14679361
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
6. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study.
Bjelland I; Tell GS; Vollset SE; Refsum H; Ueland PM
Arch Gen Psychiatry; 2003 Jun; 60(6):618-26. PubMed ID: 12796225
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly women.
Kauwell GP; Wilsky CE; Cerda JJ; Herrlinger-Garcia K; Hutson AD; Theriaque DW; Boddie A; Rampersaud GC; Bailey LB
Metabolism; 2000 Nov; 49(11):1440-3. PubMed ID: 11092508
[TBL] [Abstract][Full Text] [Related]
8. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals.
Ozarda Y; Sucu DK; Hizli B; Aslan D
Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
10. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
[TBL] [Abstract][Full Text] [Related]
11. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
12. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men.
Dekou V; Gudnason V; Hawe E; Miller GJ; Stansbie D; Humphries SE
Thromb Haemost; 2001 Jan; 85(1):67-74. PubMed ID: 11204591
[TBL] [Abstract][Full Text] [Related]
13. [Hyperhomocystinemia and 677C T methylenetetrahydrofolate reductase polymorphism as a cardiovascular risk factor in childhood].
Mainou Cid C; García Giralt N; Vilaseca Buscà MA; Ferrer Codina I; Meco López JF; Mainou Pintó A; Pintó Sala X; Grinberg Vaisman D; Balcells Comas S
An Esp Pediatr; 2002 May; 56(5):402-8. PubMed ID: 12042167
[TBL] [Abstract][Full Text] [Related]
14. [Plasma homocysteine levels in patients with ischemic heart disease].
Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
[TBL] [Abstract][Full Text] [Related]
15. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of MTHFR 677C-->T missense mutation, total plasma homocysteine levels and associated risk factors in Malay subjects.
Ling KH; Rosli R; Duraisamy G; Nasir MT
Med J Malaysia; 2003 Jun; 58(2):243-54. PubMed ID: 14569745
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia in children with renal transplants.
Aldámiz-Echevarría L; Sanjurjo P; Vallo A; Aquino L; Pérez-Nanclares G; Gimeno P; Rueda M; Ruiz I; Urreizti R; Rodríguez-Soriano J
Pediatr Nephrol; 2002 Sep; 17(9):718-23. PubMed ID: 12215824
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
